Unable to display view head.php file not found.
The Figure shows the baseline characteristics of the patients in RE-LY, which are typical of a population with AFib with associated structural disorders.[96]
The mean age was 71 years, although a significant percentage, 40%, were aged ≥75 years. As usual there were more men than women. The mean CHADS2 score was 2.2, but of note (highlighted in light blue), about one third of the patients had a CHADS2 score ≥3, which becomes relevant when comparing these results to the ROCKET AF trial with rivaroxaban (discussed below).
Reiffel JA. Am J Med 2013; 126: 00-00.
[96] Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.